MX388148B - Composicion de absorcion percutanea. - Google Patents
Composicion de absorcion percutanea.Info
- Publication number
- MX388148B MX388148B MX2018002015A MX2018002015A MX388148B MX 388148 B MX388148 B MX 388148B MX 2018002015 A MX2018002015 A MX 2018002015A MX 2018002015 A MX2018002015 A MX 2018002015A MX 388148 B MX388148 B MX 388148B
- Authority
- MX
- Mexico
- Prior art keywords
- basic
- sorbic acid
- basic drug
- preferred
- percutaneous absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2015/074553 WO2017037813A1 (ja) | 2015-08-29 | 2015-08-29 | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| PCT/JP2016/075203 WO2017038767A1 (ja) | 2015-08-29 | 2016-08-29 | 経皮吸収組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018002015A MX2018002015A (es) | 2018-06-19 |
| MX388148B true MX388148B (es) | 2025-03-19 |
Family
ID=58187853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002015A MX388148B (es) | 2015-08-29 | 2016-08-29 | Composicion de absorcion percutanea. |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9974858B2 (enExample) |
| EP (1) | EP3342423B1 (enExample) |
| JP (2) | JP6259117B2 (enExample) |
| KR (1) | KR20180039622A (enExample) |
| CN (1) | CN107427509B (enExample) |
| BR (1) | BR112018001387B8 (enExample) |
| CO (1) | CO2018001831A2 (enExample) |
| ES (1) | ES2864017T3 (enExample) |
| MX (1) | MX388148B (enExample) |
| MY (1) | MY189987A (enExample) |
| PH (1) | PH12018500271A1 (enExample) |
| RU (1) | RU2702356C2 (enExample) |
| SG (1) | SG11201800043UA (enExample) |
| UA (1) | UA123212C2 (enExample) |
| WO (2) | WO2017037813A1 (enExample) |
| ZA (1) | ZA201800296B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107427509B (zh) | 2015-08-29 | 2021-06-15 | 美德阿利克斯株式会社 | 含有碱性药物和山梨酸的经皮吸收组成物 |
| US11559519B2 (en) | 2018-01-31 | 2023-01-24 | Medrx, Co., Ltd. | Tizanidine therapy system |
| US11186585B2 (en) | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| TWI772807B (zh) * | 2019-05-27 | 2022-08-01 | 日商救急藥品工業股份有限公司 | 外用製劑 |
| CA3149152A1 (en) * | 2019-08-11 | 2021-02-18 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| CA3168199A1 (en) | 2020-02-19 | 2021-08-26 | Eri ICHIBAYASHI | Transdermal absorption preparation |
| US12103639B2 (en) * | 2021-06-03 | 2024-10-01 | Sram, Llc | Bicycle control system |
| US20240374544A1 (en) * | 2021-08-30 | 2024-11-14 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid |
| CA3232272A1 (en) * | 2021-10-15 | 2023-04-20 | Hans-Werner Wolf | Transdermal therapeutic system for the transdermal administration of tizanidine |
| CN116370439A (zh) * | 2022-04-01 | 2023-07-04 | 江苏山信药业有限公司 | 一种伐尼克兰透皮贴剂及其制备方法和其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61172830A (ja) * | 1985-01-26 | 1986-08-04 | Showa Denko Kk | 皮膚外用剤組成物 |
| CA2378385C (en) * | 1999-07-27 | 2009-01-27 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use including an acid addition salt of a basic drug |
| US20040142024A1 (en) | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
| DE602005017753D1 (de) * | 2004-03-19 | 2009-12-31 | Mcneil Ab | Mittel für die transdermale verabreichung von nikotin |
| JP4807974B2 (ja) * | 2005-06-30 | 2011-11-02 | 帝國製薬株式会社 | 経皮吸収促進組成物 |
| CN101032474B (zh) * | 2006-03-06 | 2011-02-16 | 重庆医药工业研究院有限责任公司 | 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法 |
| CN101143127A (zh) * | 2007-10-25 | 2008-03-19 | 复旦大学 | 一种酚妥拉明外用制剂及其制备方法 |
| CN103239721B (zh) | 2007-11-22 | 2016-03-16 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
| JP5537412B2 (ja) | 2008-02-27 | 2014-07-02 | 久光製薬株式会社 | 貼付製剤 |
| WO2010016219A1 (ja) | 2008-08-05 | 2010-02-11 | 株式会社メドレックス | 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法 |
| JP2012158521A (ja) * | 2009-04-17 | 2012-08-23 | Kureha Corp | 外用剤 |
| EP2476414B1 (en) * | 2009-09-07 | 2015-03-04 | NIPRO Patch Co., Ltd. | Transdermally absorbable preparation |
| WO2011157449A1 (en) * | 2010-06-18 | 2011-12-22 | Merz Pharma Gmbh & Co. Kgaa | Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives |
| US10543275B2 (en) * | 2012-06-20 | 2020-01-28 | Medrx Co., Ltd. | Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder |
| JP2014125483A (ja) | 2012-12-27 | 2014-07-07 | Lion Corp | 貼付剤 |
| CN107427509B (zh) * | 2015-08-29 | 2021-06-15 | 美德阿利克斯株式会社 | 含有碱性药物和山梨酸的经皮吸收组成物 |
-
2015
- 2015-08-29 CN CN201580078659.1A patent/CN107427509B/zh active Active
- 2015-08-29 WO PCT/JP2015/074553 patent/WO2017037813A1/ja not_active Ceased
-
2016
- 2016-08-29 KR KR1020187001366A patent/KR20180039622A/ko not_active Withdrawn
- 2016-08-29 EP EP16841799.6A patent/EP3342423B1/en active Active
- 2016-08-29 WO PCT/JP2016/075203 patent/WO2017038767A1/ja not_active Ceased
- 2016-08-29 RU RU2018110617A patent/RU2702356C2/ru active
- 2016-08-29 SG SG11201800043UA patent/SG11201800043UA/en unknown
- 2016-08-29 MY MYPI2018700724A patent/MY189987A/en unknown
- 2016-08-29 BR BR112018001387A patent/BR112018001387B8/pt active IP Right Grant
- 2016-08-29 MX MX2018002015A patent/MX388148B/es unknown
- 2016-08-29 UA UAA201803201A patent/UA123212C2/uk unknown
- 2016-08-29 ES ES16841799T patent/ES2864017T3/es active Active
- 2016-08-29 JP JP2016558808A patent/JP6259117B2/ja active Active
- 2016-09-28 US US15/279,210 patent/US9974858B2/en active Active
-
2017
- 2017-06-08 JP JP2017113200A patent/JP2017149782A/ja active Pending
-
2018
- 2018-01-16 ZA ZA2018/00296A patent/ZA201800296B/en unknown
- 2018-02-06 PH PH12018500271A patent/PH12018500271A1/en unknown
- 2018-02-22 CO CONC2018/0001831A patent/CO2018001831A2/es unknown
- 2018-04-23 US US15/960,392 patent/US10588973B2/en active Active
-
2020
- 2020-02-05 US US16/782,988 patent/US11382978B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018001387B1 (pt) | 2023-09-05 |
| US20170056502A1 (en) | 2017-03-02 |
| CN107427509B (zh) | 2021-06-15 |
| JPWO2017038767A1 (ja) | 2017-09-07 |
| US10588973B2 (en) | 2020-03-17 |
| EP3342423A4 (en) | 2018-07-25 |
| ES2864017T3 (es) | 2021-10-13 |
| RU2702356C2 (ru) | 2019-10-08 |
| UA123212C2 (uk) | 2021-03-03 |
| JP2017149782A (ja) | 2017-08-31 |
| US9974858B2 (en) | 2018-05-22 |
| US11382978B2 (en) | 2022-07-12 |
| BR112018001387A2 (pt) | 2018-09-11 |
| WO2017037813A1 (ja) | 2017-03-09 |
| EP3342423B1 (en) | 2021-03-10 |
| RU2018110617A3 (enExample) | 2019-09-30 |
| MX2018002015A (es) | 2018-06-19 |
| PH12018500271A1 (en) | 2018-08-13 |
| CN107427509A (zh) | 2017-12-01 |
| RU2018110617A (ru) | 2019-09-30 |
| ZA201800296B (en) | 2019-04-24 |
| US20200171156A1 (en) | 2020-06-04 |
| JP6259117B2 (ja) | 2018-01-10 |
| MY189987A (en) | 2022-03-22 |
| BR112018001387B8 (pt) | 2024-03-05 |
| US20180236082A1 (en) | 2018-08-23 |
| KR20180039622A (ko) | 2018-04-18 |
| EP3342423A1 (en) | 2018-07-04 |
| WO2017038767A1 (ja) | 2017-03-09 |
| SG11201800043UA (en) | 2018-02-27 |
| CO2018001831A2 (es) | 2018-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500271A1 (en) | A percutaneous absorption composition | |
| JOP20200011A1 (ar) | مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp | |
| CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
| BR112018016433A2 (pt) | inibidores de heteroarila de pad4 | |
| BR112018005194A2 (pt) | processo de composto antifúngico | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| MX2020010344A (es) | Mezcla fertilizante que contiene inhibidor de la nitrificacion. | |
| BR112015029495A2 (pt) | compostos heterocíclicos como inibidores da via de sinalização hedgehog | |
| EA201790070A1 (ru) | Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70 | |
| BR112015028173A2 (pt) | inibidores de acc e usos dos mesmos | |
| EA201691156A1 (ru) | Пирролидиноновые гербициды | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| BR112015024770B8 (pt) | formulação biocida e método para tratamento de água | |
| BR112018005200A2 (pt) | liberação de nanopartículas de fármaco e métodos de uso dos mesmos | |
| BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
| MX363457B (es) | Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1). | |
| EA201891409A1 (ru) | Бензамидные соединения и их применение в качестве гербицидов | |
| EP3398947A4 (en) | NITROGENIC CONDENSED HETEROCYCLIC COMPOUND, AND MANUFACTURING METHOD, INTERMEDIATE PRODUCTS, COMPOSITION, AND APPLICATION THEREOF | |
| MX383254B (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| PH12016502130B1 (en) | Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect | |
| EP3586848A4 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A COMPOUND SUITABLE TO CROSS THE HEMATOENCEPHALIC BARRIER AS AN ACTIVE PRINCIPLE TO PREVENT OR TREAT BRAIN CANCER | |
| BR112015020222A2 (pt) | compostos de azetidiniloxifenilpirrolidina | |
| BR112015000275A2 (pt) | utilização de um extrato de mirta como agente anti-biopelícula face p. acnes | |
| BR112017004991A2 (pt) | compostos antimicrobianos de imidazólio | |
| EA201590269A1 (ru) | Трансдермальный препарат, содержащий ингибиторы cox |